サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1786981

ペプチド治療薬の世界市場、規模、シェア、動向、産業分析レポート：タイプ別、メーカー別、投与経路別、合成技術別、用途別、地域別 - 市場予測（2025年～2034年）

Peptide Therapeutics Market Size, Share, Trends, & Industry Analysis Report By Type (Generic and Innovative), By Type of Manufacturers, By Route of Administration, By Synthesis Technology, By Application, and By Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 128 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
ペプチド治療薬の世界市場、規模、シェア、動向、産業分析レポート：タイプ別、メーカー別、投与経路別、合成技術別、用途別、地域別 - 市場予測（2025年～2034年）
出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 128 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、世界のペプチド治療薬の市場規模は、2034年までに3,133億3,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ペプチド治療薬市場は、製薬企業やバイオテクノロジー企業が安定性、生物学的利用能、送達メカニズムを改善した高度な製剤を開発するにつれて進化しています。ペプチド合成技術や固相製造プロセスの改良が進み、製造コストが低下し、製剤の選択肢が広がっています。

さらに、規制当局が支援的な枠組みを通じて新規ペプチド医薬品の承認を促進し、市場の成長をさらに加速させています。臨床パイプラインにおけるペプチドベースの製品ポートフォリオの増加と商業化活動の活発化が、がん、代謝性疾患、感染症、希少治療領域にわたる市場拡大を後押ししています。

ペプチド治療薬市場レポートのハイライト

タイプ別では、新薬セグメントが、その優れた薬理学的特性と、腫瘍学、代謝性疾患、希少疾患にわたる難治性疾患の治療における実証された有効性により、2024年の収益シェアで市場リーダーに浮上しました。

メーカータイプ別では、バイオテクノロジー企業や専門開発企業がCDMOとの提携を増やしていることから、外部委託セグメントが勢いを増しています。

投与経路別では、非経口経路が2024年に最大の売上シェアを確保し、ペプチドベース治療に好ましい送達方法としての地位を維持しています。

北米は、最先端のヘルスケアインフラ、強固な研究能力、包括的な医療償還の枠組みを有することから、2024年のペプチド治療薬の世界市場で60.21%の圧倒的シェアを獲得しました。

アジア太平洋のペプチド治療薬市場は、予測期間中に最も速いCAGRを記録する見通しです。これは、バイオ医薬品のイノベーションに対する政府の支援が増加し、国内の医薬品開発への投資が増加しているためです。

世界の主要市場企業には、Advanced Accelerator Applications SA、AstraZeneca plc、Bayer AG、Boehringer Ingelheim International GmbH、Bracco Imaging S.p.A.、Cardinal Health, Inc.、Curium Pharma、Eckert &Ziegler SE、F. Hoffmann-La Roche Ltd.、GE HealthCare Technologies Inc.、GlaxoSmithKline plc（GSK plc）、Jubilant Radiopharma Limited、Lantheus Holdings, Inc.、Eli Lilly and Company、Mallinckrodt plcなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のペプチド治療薬市場の洞察

  • 市場スナップショット
  • ペプチド治療薬市場の力学
    • 促進要因と機会
      • 慢性疾患および代謝性疾患の有病率の上昇
      • 急速な高齢化
    • 抑制要因と課題
      • 高い製造コスト
  • PESTEL分析
  • ペプチド治療薬市場の動向
  • バリューチェーン分析

第5章 世界のペプチド治療薬市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • ジェネリック
  • 新薬

第6章 世界のペプチド治療薬市場：メーカータイプ別

  • 主な調査結果
  • イントロダクション
  • 自社
  • 外部委託

第7章 世界のペプチド治療薬市場：投与経路別

  • 主な調査結果
  • イントロダクション
  • 非経口経路
  • 経口経路
  • 肺
  • 粘膜
  • その他

第8章 世界のペプチド治療薬市場：合成技術別

  • 主な調査結果
  • イントロダクション
  • 固相ペプチド合成（SPPS）
  • 組み換えDNA技術
  • ハイブリッド技術
  • 液相ペプチド合成（LPPS）
  • その他

第9章 世界のペプチド治療薬市場：用途別

  • 主な調査結果
  • イントロダクション
  • がん
  • 代謝障害
  • 心血管疾患
  • 呼吸器疾患
  • 胃腸障害
  • 感染症

第10章 世界のペプチド治療薬市場：地域別

  • 主な調査結果
  • イントロダクション
    • ペプチド治療薬市場の評価：地域別、2020～2034年
  • 北米
    • 北米：タイプ別、2020～2034年
    • 北米：メーカー別、2020～2034年
    • 北米：投与経路別、2020～2034年
    • 北米：合成技術別、2020～2034年
    • 北米：用途別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：タイプ別、2020～2034年
    • 欧州：メーカー別、2020～2034年
    • 欧州：投与経路別、2020～2034年
    • 欧州：合成技術別、2020～2034年
    • 欧州：用途別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：タイプ別、2020～2034年
    • アジア太平洋：メーカー別、2020～2034年
    • アジア太平洋：投与経路別、2020～2034年
    • アジア太平洋：合成技術別、2020～2034年
    • アジア太平洋：用途別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：タイプ別、2020～2034年
    • 中東・アフリカ：メーカー別、2020～2034年
    • 中東・アフリカ：投与経路別、2020～2034年
    • 中東・アフリカ：合成技術別、2020～2034年
    • 中東・アフリカ：用途別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：タイプ別、2020～2034年
    • ラテンアメリカ：メーカー別、2020～2034年
    • ラテンアメリカ：投与経路別、2020～2034年
    • ラテンアメリカ：合成技術別、2020～2034年
    • ラテンアメリカ：用途別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第11章 競合情勢

  • 事業拡大・買収分析
    • 事業拡大
    • 買収
  • 提携/協業/協定/公開

第12章 企業プロファイル

  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GSK plc（GlaxoSmithKline plc）
  • Ipsen Pharma
  • Ironwood Pharmaceuticals, Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Radius Health, Inc.
  • Sanofi S.A.
図表

List of Tables:

  • Table 1 Global Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 3 Global Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 4 Global Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 5 Global Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 7 North America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 8 North America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 9 North America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 10 North America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 11 U.S.: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 12 U.S.: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 13 U.S.: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 14 U.S.: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 15 U.S.: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 16 Canada: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 17 Canada: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 18 Canada: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 19 Canada: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 20 Canada: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 21 Europe: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 22 Europe: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 23 Europe: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 24 Europe: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 25 Europe: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 26 UK: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 27 UK: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 28 UK: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 29 UK: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 30 UK: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 31 France: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 32 France: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 33 France: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 34 France: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 35 France: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Germany: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 37 Germany: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 38 Germany: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 39 Germany: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 40 Germany: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 41 Italy: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Italy: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 43 Italy: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 44 Italy: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 45 Italy: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 46 Spain: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 47 Spain: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 48 Spain: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 49 Spain: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 50 Spain: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 56 Russia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 57 Russia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 58 Russia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 59 Russia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 60 Russia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 71 China: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 72 China: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 73 China: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 74 China: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 75 China: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 76 India: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 77 India: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 78 India: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 79 India: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 80 India: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 86 Japan: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 87 Japan: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 88 Japan: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 89 Japan: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 90 Japan: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 96 South Korea: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 97 South Korea: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 98 South Korea: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 99 South Korea: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 100 South Korea: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 101 Australia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 102 Australia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 103 Australia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 104 Australia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 105 Australia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 121 UAE: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 122 UAE: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 123 UAE: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 124 UAE: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 125 UAE: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 126 Israel: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 127 Israel: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 128 Israel: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 129 Israel: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 130 Israel: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 131 South Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 132 South Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 133 South Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 134 South Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 135 South Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 141 Latin America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 142 Latin America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 143 Latin America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 144 Latin America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 145 Latin America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 146 Mexico: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 147 Mexico: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 148 Mexico: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 149 Mexico: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 150 Mexico: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 151 Brazil: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 152 Brazil: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 153 Brazil: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 154 Brazil: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 155 Brazil: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 156 Argentina: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 157 Argentina: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 158 Argentina: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 159 Argentina: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 160 Argentina: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Peptide Therapeutics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Peptide Therapeutics Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Type of Manufacturers
  • Figure 9. Global Peptide Therapeutics Market, by Type of Manufacturers, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Peptide Therapeutics Market, by Route of Administration, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Synthesis Technology
  • Figure 13. Global Peptide Therapeutics Market, by Synthesis Technology, 2024 & 2034 (USD Billion)
  • Figure 14. Market by Application
  • Figure 15. Global Peptide Therapeutics Market, by Application, 2024 & 2034 (USD Billion)
目次
Product Code: PM6027

The peptide therapeutics market size is expected to reach USD 313.33 Billion by 2034, according to a new study by Polaris Market Research. The report "Peptide Therapeutics Market Size, Share, Trends, & Industry Analysis Report By Type (Generic and Innovative), By Type of Manufacturers, By Route of Administration, By Synthesis Technology, By Application, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The peptide therapeutics market is evolving as pharmaceutical and biotechnology companies develop advanced formulations with improved stability, bioavailability, and delivery mechanisms. Growing improvements in peptide synthesis technologies and solid-phase manufacturing processes, lowered the production costs and expanded formulation options.

Additionally, regulatory agencies are facilitating the approval of novel peptide drugs through supportive frameworks, further accelerating the market growth. The growing portfolio of peptide-based products in the clinical pipeline and increasing commercialization activity are boosting market expansion across oncology, metabolic disorders, infectious diseases, and rare therapeutic areas.

Peptide Therapeutics Market Report Highlights

In terms of type, the innovative peptide therapeutics segment emerged as the market leader in revenue share during 2024 due its superior pharmacological properties and proven effectiveness in treating challenging conditions across oncology, metabolic disorders, and rare diseases.

In terms of type of manufacturers, the outsourced manufacturing segment is gaining momentum as biotech firms and specialty developers increasingly partner with CDMOs.

Based on route of administration, the parenteral route segment secured the largest revenue share in 2024, maintaining its position as the preferred delivery method for peptide-based treatments.

North America captured a dominant 60.21% share of the global peptide therapeutics market in 2024 due to the region's cutting-edge healthcare infrastructure, robust research capabilities, and comprehensive medical reimbursement frameworks.

The Asia Pacific peptide therapeutics market is poised to register the fastest CAGR during the forecast period due to increasing governmental support for biopharmaceutical innovation, with investments in domestic drug development.

A few global key market players include Advanced Accelerator Applications SA, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bracco Imaging S.p.A., Cardinal Health, Inc., Curium Pharma, Eckert & Ziegler SE, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., GlaxoSmithKline plc (GSK plc), Jubilant Radiopharma Limited, Lantheus Holdings, Inc., Eli Lilly and Company, and Mallinckrodt plc.

Polaris Market Research has segmented the market report on the basis of type, type of manufacturers, route of administration, synthesis technology, application, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Generic

Innovative

By Type of Manufacturers Outlook (Revenue, USD Billion, 2020-2034)

In-house

Outsourced

By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)

Parenteral Route

Oral Route

Pulmonary

Mucosal

Others

By Synthesis Technology Outlook (Revenue, USD Billion, 2020-2034)

Solid Phase Peptide Synthesis (SPPS)

Recombinant DNA Technology

Hybrid Technology

Liquid-Phase Peptide Synthesis (LPPS)

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

Cancer

Metabolic Disorders

Cardiovascular Disorders

Respiratory Disorders

Gastrointestinal Disorders

Infectious Diseases

Pain

Dermatological Disorders

Neurological Disorders

Renal Disorders

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Peptide Therapeutics Market Insights

  • 4.1. Peptide Therapeutics Market - Market Snapshot
  • 4.2. Peptide Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic and Metabolic Diseases
      • 4.2.1.2. Rapid Aging Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Manufacturing Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Peptide Therapeutics Market Trends
  • 4.6. Value Chain Analysis

5. Global Peptide Therapeutics Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Generic
    • 5.3.1. Global Peptide Therapeutics Market, by Generic, by Region, 2020-2034 (USD Billion)
  • 5.4. Innovative
      • 5.4.1.1. Global Peptide Therapeutics Market, by Innovative, by Region, 2020-2034 (USD Billion)

6. Global Peptide Therapeutics Market, by Type of Manufacturers

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
  • 6.3. In-house
    • 6.3.1. Global Peptide Therapeutics Market, by In-house, by Region, 2020-2034 (USD Billion)
  • 6.4. Outsourced
    • 6.4.1. Global Peptide Therapeutics Market, by Outsourced, by Region, 2020-2034 (USD Billion)

7. Global Peptide Therapeutics Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
  • 7.3. Parenteral Route
    • 7.3.1. Global Peptide Therapeutics Market, by Parenteral Route, by Region, 2020-2034 (USD Billion)
  • 7.4. Oral Route
    • 7.4.1. Global Peptide Therapeutics Market, by Oral Route, by Region, 2020-2034 (USD Billion)
  • 7.5. Pulmonary
    • 7.5.1. Global Peptide Therapeutics Market, by Pulmonary, by Region, 2020-2034 (USD Billion)
  • 7.6. Mucosal
    • 7.6.1. Global Peptide Therapeutics Market, by Mucosal, by Region, 2020-2034 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Peptide Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Peptide Therapeutics Market, by Synthesis Technology

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
  • 8.3. Solid Phase Peptide Synthesis (SPPS)
    • 8.3.1. Global Peptide Therapeutics Market, by Solid Phase Peptide Synthesis (SPPS), by Region, 2020-2034 (USD Billion)
  • 8.4. Recombinant DNA Technology
    • 8.4.1. Global Peptide Therapeutics Market, by Recombinant DNA Technology, by Region, 2020-2034 (USD Billion)
  • 8.5. Hybrid Technology
    • 8.5.1. Global Peptide Therapeutics Market, by Hybrid Technology, by Region, 2020-2034 (USD Billion)
  • 8.6. Liquid-Phase Peptide Synthesis (LPPS)
    • 8.6.1. Global Peptide Therapeutics Market, by Liquid-Phase Peptide Synthesis (LPPS), by Region, 2020-2034 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Peptide Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Peptide Therapeutics Market, by Application

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.3. Cancer
    • 9.3.1. Global Peptide Therapeutics Market, by Cancer, by Region, 2020-2034 (USD Billion)
  • 9.4. Metabolic Disorders
    • 9.4.1. Global Peptide Therapeutics Market, by Metabolic Disorders, by Region, 2020-2034 (USD Billion)
  • 9.5. Cardiovascular Disorders
    • 9.5.1. Global Peptide Therapeutics Market, by Cardiovascular Disorders, by Region, 2020-2034 (USD Billion)
  • 9.6. Respiratory Disorders
    • 9.6.1. Global Peptide Therapeutics Market, by Respiratory Disorders, by Region, 2020-2034 (USD Billion)
  • 9.7. Gastrointestinal Disorders
    • 9.7.1. Global Peptide Therapeutics Market, by Gastrointestinal Disorders, by Region, 2020-2034 (USD Billion)
  • 9.8. Infectious Diseases
    • 9.8.1. Global Peptide Therapeutics Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)

10. Global Peptide Therapeutics Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Peptide Therapeutics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Peptide Therapeutics Market - North America
    • 10.3.1. North America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 10.3.2. North America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
    • 10.3.3. North America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.3.4. North America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
    • 10.3.5. North America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.3.6. Peptide Therapeutics Market - U.S.
      • 10.3.6.1. U.S.: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.3.6.2. U.S.: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.3.6.3. U.S.: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.6.4. U.S.: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.3.6.5. U.S.: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.3.7. Peptide Therapeutics Market - Canada
      • 10.3.7.1. Canada: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.3.7.2. Canada: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.3.7.3. Canada: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.7.4. Canada: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.3.7.5. Canada: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 10.4. Peptide Therapeutics Market - Europe
    • 10.4.1. Europe: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.6. Peptide Therapeutics Market - UK
      • 10.4.6.1. UK: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.7. Peptide Therapeutics Market - France
      • 10.4.7.1. France: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.8. Peptide Therapeutics Market - Germany
      • 10.4.8.1. Germany: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.9. Peptide Therapeutics Market - Italy
      • 10.4.9.1. Italy: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.10. Peptide Therapeutics Market - Spain
      • 10.4.10.1. Spain: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.11. Peptide Therapeutics Market - Netherlands
      • 10.4.11.1. Netherlands: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.12. Peptide Therapeutics Market - Russia
      • 10.4.12.1. Russia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.4.13. Peptide Therapeutics Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 10.5. Peptide Therapeutics Market - Asia Pacific
    • 10.5.1. Asia Pacific: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.6. Peptide Therapeutics Market - China
      • 10.5.6.1. China: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.7. Peptide Therapeutics Market - India
      • 10.5.7.1. India: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.8. Peptide Therapeutics Market - Malaysia
      • 10.5.8.1. Malaysia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.9. Peptide Therapeutics Market - Japan
      • 10.5.9.1. Japan: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.10. Peptide Therapeutics Market - Indonesia
      • 10.5.10.1. Indonesia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.11. Peptide Therapeutics Market - South Korea
      • 10.5.11.1. South Korea: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.12. Peptide Therapeutics Market - Australia
      • 10.5.12.1. Australia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.5.13. Peptide Therapeutics Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 10.6. Peptide Therapeutics Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.6.6. Peptide Therapeutics Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.6.7. Peptide Therapeutics Market - UAE
      • 10.6.7.1. UAE: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.6.8. Peptide Therapeutics Market - Israel
      • 10.6.8.1. Israel: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.6.9. Peptide Therapeutics Market - South Africa
      • 10.6.9.1. South Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.6.10. Peptide Therapeutics Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 10.7. Peptide Therapeutics Market - Latin America
    • 10.7.1. Latin America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.7.6. Peptide Therapeutics Market - Mexico
      • 10.7.6.1. Mexico: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.7.7. Peptide Therapeutics Market - Brazil
      • 10.7.7.1. Brazil: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.7.8. Peptide Therapeutics Market - Argentina
      • 10.7.8.1. Argentina: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 10.7.9. Peptide Therapeutics Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Peptide Therapeutics Market, by Type, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Peptide Therapeutics Market, by Type of Manufacturers, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Peptide Therapeutics Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Peptide Therapeutics Market, by Synthesis Technology, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Peptide Therapeutics Market, by Application, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Amgen Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. AstraZeneca PLC
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eli Lilly and Company
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. F. Hoffmann-La Roche Ltd
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. GSK plc (GlaxoSmithKline plc)
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Ipsen Pharma
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Ironwood Pharmaceuticals, Inc.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Novartis AG
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Novo Nordisk A/S
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Pfizer Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Radius Health, Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Sanofi S.A.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development